Home » Newsletters » BioWorld Science

BioWorld Science

July 20, 2016

View Archived Issues

USP11 shows promise as a therapeutic target in breast cancer

Angle initiates European ovarian cancer study

Iron Horse Diagnostics and Euroimmun enter license agreement to launch first ALS biologic diagnostic

AstraZeneca receives European approval for Qtern

FDA grants orphan drug designation to combination of antibodies against Ebola

FORMA Therapeutics reports ubiquitin hydrolase inhibitors

Novira Therapeutics reveals antiviral compounds to treat hepatitis B

Merck KGaA initiates phase II trial in children with schistosomiasis

Eurpean Commission grants orphan drug designation to Alcobra's metadoxine

FDA advisory committee votes to recommend brodalumab for moderate to severe plaque psoriasis

Research identifies PARG as a potential target for breast cancer

Johnson & Johnson reflects on accomplishments of second quarter 2016

Synaffix platform technologies generate ADCs with improved therapeutic index

Genetic variation in a lincRNA gene is associated with pneumococcal bacteremia

Aeglea updates progress of AEB-1102 clinical program

Scientists discover novel ROMK inhibitor SHR-1977 for treating hypertension

Topline results from Arbutus' phase I/II study of TKM-PLK1 in HCC

Jounce Therapeutics and Celgene establish immuno-oncology collaboration

ProQR Therapeutics announces fast track designation from the FDA for QR-010

BladderPredict diagnostic tool launched for bladder cancer

Cynapsus Therapeutics reaches agreement with the EMA for APL-130277 development

FDA grants fast track designation to CRLX-101

Immune Pharmaceuticals enters agreement with NPT for AmiKet

Eisai and Arena Pharmaceuticals obtain NDA approval for Belviq XR

First-in-human trial begins for GLS-5700 vaccine against Zika virus

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...